Fig. 5
A dose-response sigmoid curve in a logarithmic concentration of hepatoblastoma cell line (HepG2) 48 h post-treatment with (A) MOF, (B) SOR, and (C) SOR-MIL-53 nanocomposites.
Fig. 5 | Scientific Reports
A dose-response sigmoid curve in a logarithmic concentration of hepatoblastoma cell line (HepG2) 48 h post-treatment with (A) MOF, (B) SOR, and (C) SOR-MIL-53 nanocomposites.
